There is good news and bad news on Thoratec Corporation (NASDAQ: THOR) today. The bad news is that it did have a FDA news recall of its HeartMate II® Left Ventricular ... Read Full Story »
Thoratec Corporation (NASDAQ: THOR) took it on the chin today after news came out about the Food & Drug Administration recalling the company's HeartMate II as the left ventricular-assist system. What is interesting ... Read Full Story »
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Monday morning. Akamai Technologies, Inc. (NASDAQ: AKAM) Cut to Sell ... Read Full Story »
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning. Annaly Capital Management, Inc. (NYSE: NLY) Started as Market Perform ... Read Full Story »
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning. Alcatel-Lucent (NYSE: ALU) Reiterated Hold at Argus. Analog Devices Inc. ... Read Full Story »
New day trading alerts from VSInvestorA 33% run-up in Bankrate (RATE), for more details.Thoratec (THOR) up 12%, details. (more...) ... Read Full Story »
Thoratec Corporation (NASDAQ: THOR) is having a rough morning. The heart failure device company has a product recall it announced last Friday, and medical device recalls are not what the ... Read Full Story »